Globus Medical
GMED
268 hedge funds and large institutions have $3.4B invested in Globus Medical in 2019 Q3 according to their latest regulatory filings, with 45 funds opening new positions, 87 increasing their positions, 91 reducing their positions, and 35 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 3 → 6 (+3)
47% more call options, than puts
Call options by funds: $6.84M | Put options by funds: $4.66M
29% more first-time investments, than exits
New positions opened: 45 | Existing positions closed: 35
18% more capital invested
Capital invested by funds: $2.88B → $3.4B (+$527M)
3% more funds holding
Funds holding: 259 → 268 (+9)
0.07% more ownership
Funds ownership: 88.81% → 88.88% (+0.07%)
4% less repeat investments, than reductions
Existing positions increased: 87 | Existing positions reduced: 91
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCM
Consonance Capital Management
New York
|
+$62.5M |
| 2 |
Janus Henderson Group
London,
United Kingdom
|
+$48.2M |
| 3 |
GKIM
GW&K Investment Management
Boston,
Massachusetts
|
+$18M |
| 4 |
Millennium Management
New York
|
+$15.1M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
+$9.67M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AQR Capital Management
Greenwich,
Connecticut
|
-$24.2M |
| 2 |
NI
Nuance Investments
Kansas City,
Missouri
|
-$21.4M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
-$19M |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$18.4M |
| 5 |
N
Nuveen
Charlotte,
North Carolina
|
-$15M |
GMED Hedge Fund Activity: Q3 2019 in Review
268 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Globus Medical (GMED) for Q3 2019, worth a combined $3.4B — up 18% from $2.88B a quarter earlier.
Buyers outnumbered sellers: 45 funds opened new GMED positions and 35 closed out — a net gain of 10 holders — while 87 added to existing stakes and 91 trimmed.
The largest buyer was Consonance Capital Management, opening a new position worth an estimated $62.5M. The largest seller was AQR Capital Management, cutting an estimated $24.2M.
- 268 institutional investors held Globus Medical (GMED) as of Q3 2019, up from 259 in Q2 2019.
- Funds reported $3.4B of Globus Medical stock for Q3 2019, up 18% quarter-over-quarter.
- 45 funds opened new Globus Medical positions in Q3 2019 and 35 closed out, a net change of +10 holders.
- The largest Globus Medical buyer in Q3 2019 was Consonance Capital Management, an estimated $62.5M added.
- The largest Globus Medical seller in Q3 2019 was AQR Capital Management, an estimated $24.2M sold.
Based on aggregated 13F filings for Q3 2019.